Pathologic margin involvement and the risk of recurrence in patients treated with breast‐conserving therapy-Reference-Cited by-同舟云学术

Pathologic margin involvement and the risk of recurrence in patients treated with breast‐conserving therapy

Published:1996-11 Issue:9 Volume:78 Page:1921-1928
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Gage Irene¹²,Schnitt Stuart J.³,Nixon Asa J.¹,Silver Barbara¹,Recht Abram¹,Troyan Susan L.⁴,Eberlein Timothy⁵,Love Susan M.⁶,Gelman Rebecca²,Harris Jay R.¹,Connolly James L.⁷

Affiliation:

1. Joint Center for Radiation Therapy, Beth Israel Hospital, Harvard Medical School, Boston, Massachusetts.

2. Johns Hopkins Oncology Center, Radiation Oncology Division, Baltimore, Maryland.

3. Department of Pathology, Beth Israel Hospital, Harvard Medical School, Boston, Massachusetts.

4. Department of Surgery, Beth Israel Hospital, Harvard Medical School, Boston, Massachusetts.

5. Department of Surgery, Brigham and Women's Hospital, Harvard Medical School Boston, Massachusetts.

6. Revlon Breast Center, Department of Surgery, UCLA Medical School, Los Angeles, California.

7. Departments of Biostatistics and Epidemiology, Dana Farber Cancer Institute and Harvard School of Public Health, Boston, Massachusetts.

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/%28SICI%291097-0142%2819961101%2978%3A9%3C1921%3A%3AAID-CNCR12%3E3.0.CO%3B2-%23

Reference26 articles.

1. Eight-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast Cancer

2. Ten-Year Results of a Comparison of Conservation with Mastectomy in the Treatment of Stage I and II Breast Cancer

3. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer

4. Time-course of local recurrence following conservative surgery and radiotherapy for early stage breast cancer

5. The Optimal Extent of Resection for Patients With Stages I or II Breast Cancer Treated With Conservative Surgery and Radiotherapy

Cited by 291 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined modality treatment of early breast cancer. Literature review;Siberian journal of oncology;2024-01-05

2. Automatic diagnosis and classification of breast surgical samples with dynamic full-field OCT and machine learning;Journal of Medical Imaging;2023-06-01

3. Comparison of margin assessment between intraoperative digital and conventional specimen mammography in breast cancer: A preliminary study;Asian Journal of Surgery;2023-05

4. Quantitative tumor depth determination using dual wavelength excitation fluorescence;Biomedical Optics Express;2022-10-06

5. Assessing Resection Margin Status in Breast-conserving Surgery Specimens: Comparison Among Gross Evaluation, Frozen Section Analysis, and Permanent Section Diagnosis in 725 Patients With Breast Cancer;Anticancer Research;2022-08-23